• Consumer Stories
  • People-first Pharmacy Care

Serving our Communities During the Pandemic

May 10th, 2021

An Increased Need for Mental Health Services

A recent poll from the Kaiser Family Foundation found that four in 10 U.S. adults reported symptoms of anxiety or depression amid the pandemic, up from one in 10 adults in 2019.

Factors like isolation, loss of income, fear and grief have led to this increase, according to the World Health Organization, resulting in an increased demand for mental health services.

Genoa Healthcare Pharmacist Ginger Clark has seen firsthand the pandemic’s impact on her consumers.

“(They) have definitely been affected by COVID-19,” said Clark. “Being homebound and not having that socialization has been very tough on them.”

Clark’s pharmacy, located within Horizon Health & Wellness in Casa Grande, Arizona, serves a high population of consumers with mental illness. Learn what recent availability of COVID-19 vaccine for Genoa’s consumers means to her—and to other pharmacists and mental health care providers—in the video below.

Recent Posts


  • Behavioral Health
  • Clinical Insights
  • Partnering with Genoa
CMS reporting now required: 4 ways Genoa can help

By Reena Neumann, PharmD, MBA Since January 1, 2024, the Centers for Medicare & Medicaid Services (CMS) has required that clinics provide outcomes data reporting to secure federal funding through...

  • Consumer Stories
  • People-first Pharmacy Care
For people in crisis, access to a safe place is critical

Content warning: This post discusses mental illness and substance use. Please call the Suicide and Crisis Lifeline at 988, the Substance Abuse and Mental Health Services Administration’s National Helpline at...

  • Consumer Stories
  • People-first Pharmacy Care
Genoa pharmacist saves the life of someone she’s never met

Having witnessed the effects of the opioid crisis in her community firsthand, Genoa Healthcare® Pharmacist Kristen Pyland had prepared for the day she’d need to rush into action to aid...

Partner with Genoa
  • Behavioral Health
  • Clinical Insights
  • Treatment
Brixadi®: 3 things to know about the buprenorphine treatment option

Staying on top of new medication therapy options for your consumers living with opioid use disorder (OUD) can be difficult. Learn how the new FDA-approved medication, Brixadi®, can help support...